Cognos Therapeutics vs Synthace
Cognos Therapeutics vs Synthace, compared side by side on 9 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cognos Therapeutics is on 8/100 and Synthace on 62/100.
Where each one leads
Cognos Therapeutics
- agent readiness: 50/100 against 43/100
Synthace
- our overall score: 62/100 against 8/100
At a glance
| Measure | Cognos Therapeutics | Synthace |
|---|---|---|
| What it is | Cognos Therapeutics is developing a novel therapeutic approach for neurodegenerative diseases. | Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | Not published | 2011 |
| Headquarters | Tel Aviv, Israel | London, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Cognos Therapeutics | Synthace |
|---|---|---|
| Employees | Not published | 37 |
| Total funding | Not published | $60.6M |
| Latest round | Not published | Series C |
| LinkedIn followers | Not published | 14,388 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cognos Therapeutics | Synthace |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 8/100 | 62/100 |
| Traction | Not published | 55/100 |
| Team | Not published | 70/100 |
| Search visibility | 10/100 | 35/100 |
| Quality | Not published | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | D (43/100) |
| Domain ratingLink authority, 0-100 | Not published | 54/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cognos Therapeutics | Synthace |
|---|---|---|
| CDN | Not detected | Cloudflare |
| Analytics | Not detected | Google Tag Manager, Microsoft Clarity, Hotjar |
| Support stack | Not detected | HubSpot |
Cognos Therapeutics vs Synthace: common questions
Which is better, Cognos Therapeutics or Synthace?
On our 0-100 score Synthace rates higher (62/100 against 8/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 9 data points above: read the rows that match what you are buying for.
How do Cognos Therapeutics and Synthace compare on the numbers?
Cognos Therapeutics leads on agent readiness (50/100 against 43/100). Synthace leads on our overall score (62/100 against 8/100).
Read the full Cognos Therapeutics review and pricing or the Synthace review and pricing. You can also browse other Cognos Therapeutics alternatives we track.